Marsh & McLennan Companies (MRSH)
Coverage summary
Aardvark Labs Capital Research has covered Marsh & McLennan Companies (MRSH) since July 18, 2025. The company is in the Financial Services sector. This page lists 6 reports: 6 earnings recaps.
The latest is the Q3 2026 Earnings Recap, published October 22, 2026. The current rating is Outperform, unchanged since the Q4 2025 Earnings Recap of January 30, 2026. The rating has changed once since coverage began.
Translations: 5 in Chinese.
Rating history
All MRSH reports
Recap: Q3 2026
Organic Holds at 5% and Thrive Grows to $600M, but the Margin Stays Flat: The 19th Year Now Rides on Q4 Alone
Recap: Q2 2026
Organic Reaccelerates to 5% and the Payout Jumps 10%, But the H1 Margin Stalls: The 19th Year Rests on the Back Half
Recap: Q1 2026
Marsh Risk Re-Accelerates and the Market Looks Through a $425M Charge: Thesis on Track
Recap: Q4 2025
Quality on Sale: A Stable 2026 Guide and a Data-Center Growth Leg Meet an 18x Multiple
Recap: Q3 2025
An EPS Beat Met an 8.5% Sell-Off: The De-Rating Arrives as Growth Resets Lower
Recap: Q2 2025
Quality Compounder Beats Again, But a Faded Pop and 4% Organic Cap the Upside